Evidence map›Paper›PMID 32313806›Full record

ArticleZeitschrift fur Gesundheitswissenschaften = Journal of public health2022

2019 Novel coronavirus (COVID-19) overview.

Mehrdad Mohammadi, Maryam Meskini, Anderia Lucia do Nascimento Pinto

Abstract read
In one paragraph

Article in Zeitschrift fur Gesundheitswissenschaften = Journal of public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Review
  2. Evaluation of diagnostic performance of SARS-CoV-2 detection kits: a comparative study.Beni-Suef University journal of basic and applied sciences · 2023
    Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. An Overview on the Epidemiology and Immunology of COVID-19.Journal of infection and public health · 2021
    Review
  10. Article
  11. Article
  12. Review
  13. The bioaerosols emitted from toilet and wastewater treatment plant: a literature review.Environmental science and pollution research international · 2021
    Review
  14. Review
  15. Review
  16. Article
  17. The impact of spike mutated variants of SARS-CoV2 [Alpha, Beta, Gamma, Delta, and Lambda] on the efficacy of subunit recombinant vaccines.The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Mehrdad MohammadiDepartment of Microbiology, Faculty of Medicine, Kashan University of Medical Sciences, Kashan, Iran.
Maryam MeskiniDepartment of Mycobacteriology and Pulmonary Research, Pasteur Institute of Iran, Tehran, Iran.
Anderia Lucia do Nascimento PintoNational Health Service (NHS), London, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Novel coronaviruses (CoVs) are zoonotic pathogens, but the first human-to-human transmission has been reported. CoVs have the best known genome of all RNA viruses, and mutations in the genome have now been found. A pneumonia of unknown cause detected in Wuhan, China, was first reported to the WHO Country Office in China on 31 December 2019. This study aims to report early findings related to COVID-19 and provide methods to prevent and treat it.

Indexed as

CoronaviruseCOVID-19Pathogen

Identifiers

PMID32313806
PMCPMC7167217

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.